0571-26280011

epi@eastpoint.com.cn

CN EN
About Us
Drawing on the unique characteristics of our customers' medical device products, we offer a tailored and personalized integrated service model that spans from preclinical to clinical research and registration consultation. Our aim is to provide comprehensive support throughout the product development lifecycle, ensuring the delivery of essential preclinical research data, conducting rigorous clinical research, and facilitating seamless registration declaration processes.
Business
Drawing on the unique characteristics of our customers' medical device products, we offer a tailored and personalized integrated service model that spans from preclinical to clinical research and registration consultation. Our aim is to provide comprehensive support throughout the product development lifecycle, ensuring the delivery of essential preclinical research data, conducting rigorous clinical research, and facilitating seamless registration declaration processes.
Business Acceptance

Business Acceptance

Drawing on the unique characteristics of our customers' medical device products, we offer a tailored and personalized integrated service model that spans from preclinical to clinical research and registration consultation. Our aim is to provide comprehensive support throughout the product development lifecycle, ensuring the delivery of essential preclinical research data, conducting rigorous clinical research.
News Center
To best serve our customers' needs, we offer a personalized integrated service model tailored to the characteristics of their medical device products. This model encompasses a comprehensive range of services from preclinical to clinical research and registration consultation, ensuring the provision of essential preclinical research data, conducting robust clinical research, and facilitating seamless registration declaration processes.
Team Introduction
Based on the unique features of the customer's medical device products, we tailor a personalized integrated service model spanning from preclinical to clinical research and registration consultation. This enables us to better assist customers by providing comprehensive support, including basic preclinical research data, clinical research, and assistance with registration declaration for the product.

Development zone leaders and their delegation visited EastPoint Innovation for research and visits

2023年06月09日

Recently, Bian Jikun, Director of the Development Zone Management Committee of Linping District, led a delegation to visit and conduct research at EastPoint Innovation. Accompanied by Deputy Director Zheng Hui and the key personnel from the Innovation and Entrepreneurship Bureau, the visit aimed to gain insights into various aspects of EastPoint Innovation.


15.jpg


During the symposium, EastPoint Innovation presented reports covering four key areas: development history, core business, investment achievements, and encountered challenges. Following the presentation, Director Bian commended EastPoint Innovation as a trailblazer in driving the high-quality development of biomedicine within Linping District. He noted the organization's effective attention to both supply and demand aspects of the market, highlighting its commendable progress since inception.

In response to the challenges faced by EastPoint Innovation, Director Bian directed the Entrepreneurship and Innovation Bureau, alongside other relevant departments, to provide support and assistance, fostering collaborative efforts to propel the biological industry's development in our region. He expressed hope that under the leadership and guidance of EastPoint Innovation, more high-end enterprises and top-tier talents in the medical device sector would choose to establish roots in Linping.

This symposium has significantly bolstered EastPoint Innovation's confidence and determination in its development trajectory. As an independent third-party service platform driven by innovative technology for medical device research and development, EastPoint Innovation remains committed to its mission and responsibility. It will continue to adhere to the principle of "accelerating scientific transformation from point to surface", striving for even greater achievements in the future.